Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Matrix M”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT05385471
What this trial is testing

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of the Blood-stage Malaria Candidate Vaccines RH5.1 in Matrix-M and R78C in Matrix-M in Healthy UK Adults

Who this might be right for
Malaria, Falciparum
University of Oxford 36
Not applicableLooking for participantsNCT07749911
What this trial is testing

Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)

Who this might be right for
MalariaPLASMODIUM FALCIPARUM MALARIA
Clinton Health Access Initiative Inc. 20,000
Very early researchEnded earlyNCT05400746
What this trial is testing

The Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

Who this might be right for
MalariaPlasmodium Falciparum
University of Oxford 17
Large-scale testing (Phase 3)Study completedNCT05468736
What this trial is testing

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Who this might be right for
COVID-19
Novavax 3,600
Not applicableLooking for participantsNCT07009847
What this trial is testing

An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

Who this might be right for
Malaria,FalciparumMorality
Serum Institute of India Pvt. Ltd. 2,308
Testing effectiveness (Phase 2)Looking for participantsNCT07779408
What this trial is testing

Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Who this might be right for
Healthy VolunteersInfluenza
Sanofi 640
Early research (Phase 1)Active Not RecruitingNCT06141057
What this trial is testing

Compare Two Dosing Regimens for a New Malaria Vaccine

Who this might be right for
MalariaMalaria,FalciparumProtozoan Infections+3 more
University of Oxford 24
Testing effectiveness (Phase 2)Study completedNCT05112848
What this trial is testing

Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Novavax 384
Large-scale testing (Phase 3)Study completedNCT04583995
What this trial is testing

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 15,185
Early research (Phase 1)Study completedNCT06507605
What this trial is testing

Dose-Escalating Study of Pfs230D1 in Combination With R21 in Matrix-M in African Adults

Who this might be right for
Prevention of Malaria Transmission and Clinical Malaria
Serum Institute of India Pvt. Ltd. 240
Large-scale testing (Phase 3)Active Not RecruitingNCT04704830
What this trial is testing

R21/Matrix-M in African Children Against Clinical Malaria

Who this might be right for
Malaria
University of Oxford 4,800
Large-scale testing (Phase 3)UnknownNCT06578572
What this trial is testing

Seasonal R21 Mass Vaccination for Malaria Elimination

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 16,200
Post-approval studies (Phase 4)Active Not RecruitingNCT07086222
What this trial is testing

Efficacy and Safety of NVX-CoV2705

Who this might be right for
COVID-19Sars-CoV-2 Infection
Novavax 6,500
Early research (Phase 1)Study completedNCT04862416
What this trial is testing

Safety and Efficacy of R0.6C Vaccine

Who this might be right for
MalariaMalaria,Falciparum
Radboud University Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT02078674
What this trial is testing

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

Who this might be right for
Influenza (Pandemic)
Novavax 610
Testing effectiveness (Phase 2)Active Not RecruitingNCT06080243
What this trial is testing

Assessment of Safety, Immunogenicity and Efficacy of R21/Matrix-M1 Malaria Vaccine in Healthy WOCBP in Mali

Who this might be right for
Healthy Women of Child Bearing Potential
University of Oxford 330
Large-scale testing (Phase 3)WithdrawnNCT06485752
What this trial is testing

Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine

Who this might be right for
COVID-19
Novavax
Early research (Phase 1)Study completedNCT05385510
What this trial is testing

Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

Who this might be right for
Malaria
University of Oxford 122
Testing effectiveness (Phase 2)Study completedNCT04368988
What this trial is testing

Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant

Who this might be right for
COVID-19
Novavax 1,419
Early research (Phase 1)Study completedNCT04318002
What this trial is testing

Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

Who this might be right for
Malaria,Falciparum
University of Oxford 60
Next Page